Skip to content

NVO

Novo Nordisk A/S

NYSE · Healthcare · Drug Manufacturers - General · DK

$39.14
+2.22%
Ask drillr

Margins

Gross margin
80.6%
EBITDA margin
54.9%
EBIT margin
43.1%
Net margin
35.3%
FCF margin
14.8%
52.6%
Return on equity
19.6%
Return on assets
39.3%
Return on invested capital
0.57x
Asset turnover
$19.9B
Cash from operations
$1.50
Cash per share

Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026